Skip to main content
. Author manuscript; available in PMC: 2017 Jun 19.
Published in final edited form as: Oncogene. 2016 Dec 19;36(23):3213–3222. doi: 10.1038/onc.2016.473

Table 1.

Function of Rho GTPases in in vivo cancer models.

Rho
GTPases
Pro- or anti-
oncogenic
Model Remarks References
(year)
RhoC Pro-oncogenic RhoC−/−; pyV-MT mouse model of
mammary tumor
Loss of RhoC did not affect tumor development but
decreases tumor cell motility and metastatic cell
survival leading to a drastic inhibition of metastasis
Hakem et
al.47 (2005)
Rac1 Pro-oncogenic Rac1flox/flox and LSL-K-RasG12D mouse, lung
infections with adenovirus expressing Cre
(Ad-Cre)
Rac1 function is required for tumorigenesis in this
oncogenic K-Ras-induced lung cancer model
Kissil et al.50
(2007)
Rac1 Pro-oncogenic Rac1flox/flox; K5-Cre mouse, treated with
DMBA/TPA to induce skin tumors
Rac1 is crucial for skin tumor formation and mice
with keratinocyte-restricted deletion of Rac1 are
resistant to skin tumor formation.
Wang et
al.52 (2010)
Rac1 Pro-oncogenic LSL-K-RasG12D; K14-Cre:ER; Rac1WT/−
mouse model of epidermal papilloma
Active Rac1 level was high in this model and genetic
removal of one Rac1 allele significantly impaired K-
Ras induced oral papilloma growth
Samuel et
al.51 (2011)
Rac1/Rac2 Pro-oncogenic Transplant of Low density bone marrow
from Rac1flox/flox; Mx1-Cre or Rac2−/−; Mx1-
Cre mouse, transfected with retrovirus
expressing MLL-AF9 to induce leukemia.
Rac2, but not Rac1, is critical to the initiation of
acute myeloid leukemia in this model; however,
loss of either Rac1 or Rac2 is sufficient to impair
survival and growth of the transformed MLL-AF9
leukemia
Mizukawa et
al.54 (2011)
RhoA/Rac1 Pro-oncogenic Oncogenic Ras driven eye hyperplasia
/tumorigenesis in Drosophila (ey-GAL4;
UAS-Ras85DV12)
Rho1, Rac1 and RhoGEF2 were identified to
enhance oncogenic Ras driven tumorigenesis in a
genome-wide screen
Brumby et
al.31 (2011)
RhoA Pro-oncogenic K-RasLA2-G12D mouse model of non-small
cell lung cancer (NSCLC)
Combined inhibition of the proteasome and ROCK
robustly suppresses K-Ras mutant tumor growth
Kumar et
al.32 (2012)
Rac1b Pro-oncogenic LSL-K-RasG12D; Rosa26-LSL-Rac1b mouse
model of lung cancer, lung infection with
adenovirus expressing Cre (Ad-Cre)
Expression of Rac1b synergized with oncogenic K-
Ras resulting in increased cellular proliferation and
accelerated tumor growth.
Zhou et al.64
(2013)
Rac1 Pro-oncogenic Rac1flox/flox; K-Ras(LSL-G12D)/+; Ptf1acre/+
mouse model of pancreatic ductal
adenocarcinoma (PDA) with pancreas-
specific deletion of Rac1
Pancreas-specific deletion of Rac1 prevented the
development of pancreatic tumors.
Wu et al.53
(2014)
Cdc42 Pro-oncogenic APCmin/+; Cdc42flox/flox; Vil-Cre or
Catnb(ex3)/+; Cdc42flox/flox; Vil-Cre mouse
model of colorectal cancer with intestinal
epithelial cell specific Cdc42 deletion
Reduction of Cdc42 alleviates the tumorigenicity of
mutant intestinal cells carrying single APC or β-
catenin mutations
Sakamori et
al.58 (2014)
RhoA Anti-oncogenic TO(K-RasG12V/RhoA), TO(K-
RasG12V/RhoAT19N), or TO(K-
RasG12V/RhoAG14V) zebra fish model of
hepatocellular carcinoma
Liver enlargement and hepatocyte proliferation
induced by tet-on-inducible, liver-specific
expression K-RasG12V was augmented by dominant-
negative RhoAT19N, but reduced by constitutive-
active RhoAG14V.
Chew et al.94
(2014)
RhoA Anti-oncogenic APCmin/+; RhoAT19N/−; Vil-Cretg/− mouse
model of colorectal cancer with
expression of dominant-negative
RhoAT19N
RhoA inactivation contributes to colorectal cancer
progression/metastasis, largely through the
activation of Wnt/β-catenin signaling
Rodrigues et
al.97 (2014)
RhoB Anti-oncogenic RhoB−/− mouse with cutaneous squamous
cell carcinomas (SCC) induced with UVB
RhoB deletion lowered the incidence of SCC
precursor tumors following chronic exposure to
UVB.
Meyer et
al.112 (2014)
Rac1 Pro-oncogenic K14-ΔNLef1; K14-Rac1Q61L mouse model
of sebaceous adenoma with epidermis-
specific active Rac1
Active Rac1 did not change the incidence or
frequency of tumors, but could suppress tumor cell
differentiation and enable malignant progression
of sebaceous tumors.
Frances et
al.56 (2015)
RhoA/RhoC Anti-oncogenic LSL-K-RasG12D with RhoAflox/flox or RhoC−/−
or both, mouse models of lung
carcinoma induced by lung infection of
adenovirus expressing Cre (Ad-Cre)
Deletion of RhoA or RhoC alone did not suppress K-
RasG12D induced lung adenoma initiation; rather,
deletion of RhoA along accelerated lung adenoma
formation.
Zandvakili et
al.98 (2015)